Revance Therapeutics Inc (NAS:RVNC)
$ 3.48 0.16 (4.82%) Market Cap: 363.48 Mil Enterprise Value: 545.47 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 59/100

Revance Therapeutics Inc (RVNC) Transcripts

  • 1